Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
暂无分享,去创建一个
M. Rocco | A. Cheung | W. Ambrosius | B. Freedman | M. Shlipak | R. Katz | W. Haley | J. Ix | K. Raphael | A. Rastogi | H. Punzi | R. Malhotra | V. Jotwani | Vasantha Jotwani
[1] L. Fried. When Increase in Serum Creatinine Doesn't Imply Kidney Damage. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[2] A. Cheung,et al. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] C. Cannon,et al. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[4] Keith C. Norris,et al. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review , 2018, BMC Nephrology.
[5] Jackson T. Wright,et al. Effects of Intensive BP Control in CKD. , 2017, Journal of the American Society of Nephrology : JASN.
[6] N. Buus,et al. Urine liver fatty acid binding protein and chronic kidney disease progression , 2017, Scandinavian journal of clinical and laboratory investigation.
[7] F. Thomé,et al. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes , 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[8] A. Levey,et al. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] L. Cantley,et al. YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation. , 2017, Journal of the American Society of Nephrology : JASN.
[10] E. Siew,et al. Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[11] R. Vasan,et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. , 2017, Kidney international.
[12] S. Nakagawa. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease]. , 2017, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[13] Mardge H. Cohen,et al. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] Sudhir V. Shah,et al. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[15] Jackson T. Wright,et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.
[16] R. Vasan,et al. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[17] D. Siscovick,et al. Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study. , 2015, Journal of the American Society of Nephrology : JASN.
[18] B. Teo,et al. Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why. , 2015, Singapore medical journal.
[19] Walter T Ambrosius,et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.
[20] R. Vasan,et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus , 2014, Diabetologia.
[21] H. Feldman,et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease , 2013, Kidney international.
[22] T. Olesen,et al. Systolic Blood Pressure Intervention Trial (SPRINT) , 2013 .
[23] D. Siscovick,et al. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] A. Köttgen,et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[26] I. D. de Boer,et al. Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study , 2010, Circulation.
[27] Y. Iwamoto,et al. Higher Levels of Urinary Albumin Excretion Within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients , 2009, Diabetes Care.
[28] D. Bolignano,et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[29] A. Howie,et al. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] 菊池 太朗,et al. ラット椎間板皮下吸収モデルにおけるMCP-1(monocyte chemoattractant protein-1)の動向について , 1996 .
[31] K. Nath,et al. Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] J. Kassirer,et al. Clinical evaluation of kidney function--glomerular function. , 1971, The New England journal of medicine.